X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (530) 530
Publication (14) 14
Book Chapter (10) 10
Patent (5) 5
Book / eBook (4) 4
Conference Proceeding (4) 4
Book Review (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (257) 257
male (212) 212
urology & nephrology (201) 201
middle aged (144) 144
aged (142) 142
adult (91) 91
urology (81) 81
cancer (77) 77
female (71) 71
prostate cancer (64) 64
index medicus (63) 63
aged, 80 and over (59) 59
prospective studies (48) 48
men (47) 47
prostatic neoplasms - pathology (42) 42
treatment outcome (36) 36
prostate-specific antigen - blood (35) 35
biopsy (34) 34
prognosis (32) 32
sensitivity and specificity (32) 32
kidney neoplasms - pathology (30) 30
prostate - pathology (30) 30
prostate (29) 29
benign prostatic hyperplasia (28) 28
carcinoma (28) 28
diagnosis (28) 28
predictive value of tests (27) 27
research (25) 25
follow-up studies (24) 24
bladder cancer (23) 23
hyperplasia (23) 23
neoplasm staging (23) 23
oncology, experimental (23) 23
risk factors (23) 23
care and treatment (22) 22
prostatic hyperplasia - therapy (22) 22
tumors (22) 22
prostatic hyperplasia - pathology (21) 21
prostatic neoplasms - blood (21) 21
retrospective studies (21) 21
risk (21) 21
oncology (20) 20
health aspects (19) 19
prostatic neoplasms - diagnosis (19) 19
time factors (19) 19
analysis (18) 18
expression (18) 18
immunohistochemistry (18) 18
surgery (18) 18
dutasteride (17) 17
experience (17) 17
kidney neoplasms - surgery (17) 17
radical prostatectomy (17) 17
antigen (16) 16
carcinoma, renal cell - pathology (16) 16
medical colleges (16) 16
prostate-specific antigen (16) 16
prostatic neoplasms (16) 16
urinary bladder neoplasms - diagnosis (16) 16
age (15) 15
finasteride (15) 15
ablation (14) 14
kidney (14) 14
reproducibility of results (14) 14
survival (14) 14
adolescent (13) 13
endocrinology & metabolism (13) 13
further section (13) 13
management (13) 13
progression (13) 13
prostatectomy (13) 13
prostatic hyperplasia - complications (13) 13
prostatic hyperplasia - drug therapy (13) 13
prostatic neoplasms - genetics (13) 13
prostatic neoplasms - surgery (13) 13
renal cell carcinoma (13) 13
testosterone (13) 13
therapy (13) 13
disease progression (12) 12
double-blind method (12) 12
genetic aspects (12) 12
laparoscopy (12) 12
microwaves - therapeutic use (12) 12
prostatic neoplasms - therapy (12) 12
testosterone - blood (12) 12
urinary bladder neoplasms - pathology (12) 12
urinary bladder neoplasms - urine (12) 12
urodynamics (12) 12
bladder (11) 11
carcinoma, renal cell (11) 11
case-control studies (11) 11
cell carcinoma (11) 11
efficacy (11) 11
follow-up (11) 11
grade (11) 11
natural-history (11) 11
nephrectomy - methods (11) 11
psa (11) 11
quality-of-life (11) 11
recurrence (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1192 - 1202
Dutasteride, an inhibitor of 5α-reductase in the prostate, was tested in a large, randomized trial to determine its ability to prevent prostate cancer. Over... 
MODELING APPROACH | MEDICINE, GENERAL & INTERNAL | DESIGN | THERAPY | 5-ALPHA-REDUCTASE INHIBITOR DUTASTERIDE | SENSITIVITY | FINASTERIDE | GRADE | HYPERPLASIA | PROGRESSION | PREVENTION TRIAL | Enzyme Inhibitors - adverse effects | Prostatic Neoplasms - pathology | Prostatic Hyperplasia - pathology | Double-Blind Method | Erectile Dysfunction - chemically induced | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Risk | Treatment Outcome | Azasteroids - therapeutic use | Enzyme Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Azasteroids - adverse effects | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Protein Isoforms | Dutasteride | Aged | Prostatic Neoplasms - prevention & control | Prostatic Hyperplasia - drug therapy | Heart Failure - chemically induced | Usage | Diagnosis | Health aspects | Prostate cancer | Risk factors | Patient safety | Age | Men | Tumors | Prostate-Specific Antigen | Erectile Dysfunction | Enzyme Inhibitors | Testosterone 5-alpha-Reductase | Prostatic Hyperplasia | Life Sciences | Prostatic Neoplasms | Azasteroids | Heart Failure | Prostate | Cancer | pathology | genetics | Urologi och njurmedicin | chemically induced | drug therapy | prevention & control | blood | adverse effects | Cancer and Oncology | Urology and Nephrology | therapeutic use | Cancer och onkologi
Journal Article
1991, Practice of surgery., ISBN 0443035229, 320
Book
1995, ISBN 1899066128, xvi, 253
Book
1985, Volume 3, no. 1., 63
Book
BJU International, ISSN 1464-4096, 11/2004, Volume 94, Issue 7, pp. 961 - 962
Journal Article
1983, ISBN 0683055852, Volume 8., xv, 346
Book
Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. e484 - e492
Journal Article
World Journal of Urology, ISSN 0724-4983, 8/2014, Volume 32, Issue 4, pp. 1033 - 1040
Journal Article